Prevalence and Correlates of Statin Underuse for Secondary Prevention of Cardiovascular Disease in Older Adults 65–79 Years of Age: The Italian Health Examination Survey 2008

Prevalence and Correlates of Statin Underuse for Secondary Prevention of Cardiovascular Disease in Older Adults 65–79 Years of Age: The Italian Health Examination Survey 2008–2012

Published:2020-10-01 Issue:5 Volume:23 Page:394-400
ISSN:1549-1684
Container-title:Rejuvenation Research
language:en
Short-container-title:Rejuvenation Research

Author:

Viscogliosi Giovanni¹²,Donfrancesco Chiara¹,Lo Noce Cinzia¹,Vanuzzo Diego³,Carle Flavia²,Giampaoli Simona¹,Palmieri Luigi¹

Affiliation:

1. Department of Cardiovascular, Dysmetabolic and Ageing-Associated Diseases, National Institute of Health, Rome, Italy.

2. Department of Epidemiology, Centre of Epidemiology and Biostatistics, Polytechnic University of Marche, Ancona, Italy.

3. Department of Cardiology, National Association Hospital Cardiologists, Florence, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Geriatrics and Gerontology,Ageing

Link

https://www.liebertpub.com/doi/pdf/10.1089/rej.2019.2268

Reference31 articles.

1. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

2. Effectiveness of Statin Therapy in Adults With Coronary Heart Disease

3. Cardiac Care for Older Adults

4. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

5. Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults;American Journal of Preventive Cardiology;2024-06

2. Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study;BMC Primary Care;2022-12-07

3. Statins and cognition: Modifying factors and possible underlying mechanisms;Frontiers in Aging Neuroscience;2022-08-15

4. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients;Clinical Interventions in Aging;2021-07

5. Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial;European Heart Journal - Cardiovascular Pharmacotherapy;2021-06-30